Leptomeningeal metastasis from solid tumors: clinical features and its diagnostic implication

[1]  S. Chuai,et al.  Unique genetic profiles from cerebrospinal fluid cell-free DNA in leptomeningeal metastases of EGFR-mutant non-small-cell lung cancer: a new medium of liquid biopsy , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

[2]  J. Vansteenkiste,et al.  Genetic profiling of cell-free DNA from cerebrospinal fluid: opening the barrier to leptomeningeal metastasis in EGFR-mutant NSCLC. , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

[3]  R. Henriksson,et al.  EANO-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours. , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

[4]  L. Deangelis,et al.  Cerebrospinal fluid circulating tumor cells: a novel tool to diagnose leptomeningeal metastases from epithelial tumors , 2017, Neuro-oncology.

[5]  A. Seidman,et al.  Characteristics and Outcomes of Patients With Breast Cancer With Leptomeningeal Metastasis , 2017, Clinical breast cancer.

[6]  M. Uhr,et al.  [Strategies for cerebrospinal fluid analysis - Integrated results report]. , 2016, Der Nervenarzt.

[7]  Y. Li,et al.  Concurrent radiotherapy and intrathecal methotrexate for treating leptomeningeal metastasis from solid tumors with adverse prognostic factors: A prospective and single‐arm study , 2016, International journal of cancer.

[8]  Jae-Won Hyun,et al.  Leptomeningeal metastasis: Clinical experience of 519 cases. , 2016, European journal of cancer.

[9]  Y. Li,et al.  Thinprep plus Papanicolaou Stain Method Is More Sensitive than Cytospin-Coupled Wright Giems Stain Method in Cerebrospinal Fluid Cytology for Diagnosis of Leptomeningeal Metastasis from Solid Tumors , 2015, PloS one.

[10]  P. Wen,et al.  Leptomeningeal metastasis: a Response Assessment in Neuro-Oncology critical review of endpoints and response criteria of published randomized clinical trials. , 2014, Neuro-oncology.

[11]  P. Wen,et al.  Leptomeningeal metastases: a RANO proposal for response criteria , 2014, Neuro-oncology.

[12]  John W. Park,et al.  Molecular profiling of tumor cells in cerebrospinal fluid and matched primary tumors from metastatic breast cancer patients with leptomeningeal carcinomatosis. , 2013, Cancer research.

[13]  Hyae-Young Kim,et al.  Impact of EGFR tyrosine kinase inhibitors versus chemotherapy on the development of leptomeningeal metastasis in never smokers with advanced adenocarcinoma of the lung , 2013, Journal of Neuro-Oncology.

[14]  S. Taillibert,et al.  Carcinomatous meningitis: Leptomeningeal metastases in solid tumors , 2013, Surgical neurology international.

[15]  M. De Carvalho Bittencourt,et al.  Detection and quantification of CSF malignant cells by the CellSearch® technology in patients with melanoma leptomeningeal metastasis , 2013, Medical Oncology.

[16]  P. Shah,et al.  Metastatic Squamous Cell Carcinoma in Cerebrospinal Fluid: Why a Rare Diagnosis on Cytology? , 2012, Acta Cytologica.

[17]  J. Connor,et al.  Detection of cancer cells in the cerebrospinal fluid: current methods and future directions , 2011, Fluids and Barriers of the CNS.

[18]  M. Chamberlain.  Leptomeningeal metastases in the MRI era , 2011, Neurology.

[19]  M. Chamberlain.  Leptomeningeal metastasis , 2010, Current opinion in oncology.

[20]  L. Jacks,et al.  Leptomeningeal metastases in the MRI era , 2010, Neurology.

[21]  S. Taillibert,et al.  Leptomeningeal metastasis , 2009, Current opinion in neurology.

[22]  W. Wilson,et al.  Diagnostic tools for neoplastic meningitis: detecting disease, identifying patient risk, and determining benefit of treatment. , 2009, Seminars in oncology.

[23]  Y. Bang,et al.  Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are effective for leptomeningeal metastasis from non-small cell lung cancer patients with sensitive EGFR mutation or other predictive factors of good response for EGFR TKI. , 2009, Lung cancer.

[24]  N. Leeds,et al.  MR imaging of leptomeningeal metastases: comparison of three sequences. , 2002, AJNR. American journal of neuroradiology.

[25]  G. Krol,et al.  Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasis , 1995, Annals of neurology.

[26]  J. Glass,et al.  Leptomeningeal metastasis , 1993, Neurology.

[27]  M. Chamberlain,et al.  Systemic therapy of brain metastases: non-small cell lung cancer, breast cancer, and melanoma. , 2017, Neuro-oncology.